Clinical Trial Update: Bone Microstructure in Nasal Salmon Calcitonin Treated Postmenopausal Women [Phase 3]

View source ↗

Summary

A Phase 3 trial in postmenopausal osteoporosis has completed and assessed bone microstructure in patients treated with nasal salmon calcitonin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Salmon Calcitonin Nasal Spray (salmon calcitonin)

Snippet

Sponsor: Rene Rizzoli | Conditions: Postmenopause | Phase 3 | Status: COMPLETED